This report identifies the global kidney function tests market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global kidney function tests market.
Geographically North America dominated global kidney function tests market, and Asia Pacific is projected to have fastest growth, owing to higher incidence rate of chronic diseases, growing patient awareness and rising demand for advanced diagnostics and therapeutics regimens for chronic kidney diseases in developing nations such as China, and India in this region. Among all the test types, concentration tests have the highest market share in global kidney function tests market.
This report segments global kidney function tests market on the basis of test types and regional market as follows:
Kidney Function Tests Market, By Test Types: Clearance Tests, Dilution, Concentration Tests, Urine Tests, and Visual Imaging Tests
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the kidney function tests market. Some of the major companies’ profiles in detail are as follows:
Metabolic Solutions Development Company, LLC
F. Hoffmann-La Roche Ltd
Otsuka Holdings Co., Ltd.
Eli Lilly and Company
Kadmon Corporation, LLC
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Kidney Function Tests Market– Market Forces
4.1.1. Growing number of individuals suffering from chronic kidney disease
4.1.2. Rise in the aging population
4.1.3. Increasing incidences and prevalence of diabetes
4.2.1. Higher cost of treatment
4.2.2. Stringent regulatory approvals
4.3.1. Emerging economies
4.3.2. Increase in incidence rate of renal fibrosis
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Kidney Function Tests Market, By Test Type
5.1. Clearance Tests
5.3. Concentration Tests
5.4. Urine Tests
5.5. Visual Imaging Tests
6. Kidney Function Tests Market, By Geography
6.1.7. Rest of Europe
6.2. Asia Pacific
6.2.4. South Korea
6.2.5. Rest of Asia-Pacific
6.3. North America
6.4. Rest of the World (RoW)
6.4.2. Rest of RoW
7. Kidney Function Tests – Market Entropy
7.2. Technological Developments
7.3. Merger & Acquisitions, and Joint Ventures
7.4. Supply- Contract
8. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
8.1. Metabolic Solutions Development Company, LLC
8.2. F. Hoffmann-La Roche Ltd
8.3. Otsuka Holdings Co., Ltd.
8.4. Eli Lilly and Company
8.5. Kadmon Corporation, LLC
8.6. Baxter International Inc.
8.7. Ipsen S.A.
8.8. Galectin Therapeutics, Inc.
8.9. Pfizer Inc.
8.10. IC-Meditech, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9.3. Research Methodology
9.4. Expert Insights